Tetragon Partners GP LTD: 13F holdings, Q2 2026
Hedge fund · SEC EDGAR filings (CIK 1515070) · Explore on the interactive board
Tetragon Partners GP LTD disclosed 32 US equity positions worth $614.3m in its Q2 2026 13F filing (holdings as of June 30, 2026, filed August 13, 2026). Its largest position is PATH at 54.8% of the reported book, followed by KGEI, AUTL. The top ten holdings are 76.5% of the book, and the portfolio behaves like about 3 equal-weight positions. Versus the prior filing it opened 5 new positions, added to 15, reduced 5 and exited 4. Note: this manager's most recent filing is 3934 quarters behind the newest quarter on file, so these figures are history rather than current positioning.
What does Tetragon Partners GP LTD own? Top holdings as of June 30, 2026
Change is measured in shares against the previous filing (Q1 2026), so price moves do not read as decisions. This quarter: 5 new, 15 added, 5 reduced, 4 exited.
| # | Stock | Sector | Weight | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|---|
| 1 | PATH UIPATH INC | Technology | 54.8% | $336.4m | 30,950,000 | 23% | added |
| 2 | KGEI KOLIBRI GLOBAL ENERGY INC | 5.5% | $33.8m | 6,834,504 | 0% | held | |
| 3 | AUTL AUTOLUS THERAPEUTICS LTD | Healthcare | 2.5% | $15.2m | 9,500,000 | 0% | held |
| 4 | LYFT LYFT INC | Technology | 2.4% | $14.6m | 1,000,000 | 0% | held |
| 5 | DFTX DEFINIUM THERAPEUTICS INC | Healthcare | 2.2% | $13.5m | 286,990 | 43% | added |
| 6 | WK WORKIVA INC | Technology | 2.0% | $12.1m | 250,000 | 0% | held |
| 7 | CXM SPRINKLR INC | Technology | 1.8% | $11.4m | 2,200,000 | 0% | held |
| 8 | MBX MBX BIOSCIENCES INC | Healthcare | 1.8% | $11.2m | 203,543 | 40% | added |
| 9 | ALKT ALKAMI TECHNOLOGY INC | Technology | 1.8% | $10.9m | 600,284 | – | new |
| 10 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 1.8% | $10.8m | 290,441 | -7% | reduced |
| 11 | RLAY RELAY THERAPEUTICS INC | Healthcare | 1.7% | $10.7m | 570,311 | 214% | added |
| 12 | ARWR ARROWHEAD PHARMACEUTICALS IN | Healthcare | 1.7% | $10.6m | 130,484 | 3% | added |
| 13 | PHVS PHARVARIS N V | Healthcare | 1.7% | $10.2m | 295,627 | 33% | added |
| 14 | ALKS ALKERMES PLC | Healthcare | 1.6% | $10.0m | 189,979 | 19% | added |
| 15 | IMVT IMMUNOVANT INC | Healthcare | 1.6% | $9.9m | 255,934 | 17% | added |
| 16 | SLN SILENCE THERAPEUTICS PLC | 1.4% | $8.4m | 764,256 | 21% | added | |
| 17 | DYN DYNE THERAPEUTICS INC | Healthcare | 1.3% | $7.9m | 356,657 | 38% | added |
| 18 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 1.3% | $7.7m | 97,173 | 133% | added |
| 19 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 1.2% | $7.6m | 205,579 | 25% | added |
| 20 | HRMY HARMONY BIOSCIENCES HLDGS IN | Healthcare | 1.2% | $7.3m | 201,036 | 68% | added |
| 21 | KRYS KRYSTAL BIOTECH INC | Healthcare | 1.2% | $7.3m | 19,668 | 0% | held |
| 22 | ANNX ANNEXON INC | Healthcare | 1.2% | $7.1m | 1,242,455 | -4% | reduced |
| 23 | CELC CELCUITY INC | Healthcare | 1.1% | $6.7m | 64,110 | – | new |
| 24 | WBD WARNER BROS DISCOVERY INC | Communication Services | 1.1% | $6.7m | 250,000 | -73% | reduced |
| 25 | NKTR NEKTAR THERAPEUTICS | Healthcare | 1.0% | $6.1m | 86,996 | -16% | reduced |
| 26 | AMLX AMYLYX PHARMACEUTICALS INC | Healthcare | 0.9% | $5.4m | 297,926 | -6% | reduced |
| 27 | ACAD ACADIA PHARMACEUTICALS INC | Healthcare | 0.7% | $4.2m | 167,875 | 16% | added |
| 28 | CUE CUE BIOPHARMA INC | 0.5% | $3.0m | 93,819 | – | new | |
| 29 | SNOW SNOWFLAKE INC | Technology | 0.4% | $2.5m | 10,000 | 0% | held |
| 30 | ACRS ACLARIS THERAPEUTICS INC | Healthcare | 0.3% | $2.1m | 400,000 | – | new |
| 31 | TECX TECTONIC THERAPEUTIC INC | Healthcare | 0.3% | $1.6m | 46,516 | 24% | added |
| 32 | GLUE MONTE ROSA THERAPEUTICS INC | Healthcare | 0.2% | $1.4m | 56,052 | – | new |
What did Tetragon Partners GP LTD sell? Positions exited since the previous filing
| Stock | Prior weight | Prior value |
|---|---|---|
| PRAX PRAXIS PRECISION MEDICINES I | 42.7% | $5.1m |
| SLNOEUR SOLENO THERAPEUTICS INC | 28.4% | $3.4m |
| MPLT MAPLIGHT THERAPEUTICS INC | 18.9% | $2.3m |
| AARD AARDVARK THERAPEUTICS INC | 9.9% | $1.2m |
Sector mix
| Sector | Weight |
|---|---|
| Technology | 63.1% |
| Healthcare | 28.4% |
| Communication Services | 1.1% |
Sectors cover positions whose ticker resolved to a sector; the remainder is unclassified, not cash.
Filing history
How concentrated is Tetragon Partners GP LTD's portfolio?
Across every quarter Tetragon Partners GP LTD has filed, its median largest position is 54.9% of the book and its median top-ten weight is 79.8%, which WhaleCreep classifies as concentrated (the gate is a median largest position of 5%). Of 7.0 completed holding spells, the median lasted 1.0 quarters; 32.0 positions are still open and their final length is unknown.